298 related articles for article (PubMed ID: 26494413)
1. Targeting truncated RXRα for cancer therapy.
Zhang X; Zhou H; Su Y
Acta Biochim Biophys Sin (Shanghai); 2016 Jan; 48(1):49-59. PubMed ID: 26494413
[TBL] [Abstract][Full Text] [Related]
2. NSAID sulindac and its analog bind RXRalpha and inhibit RXRalpha-dependent AKT signaling.
Zhou H; Liu W; Su Y; Wei Z; Liu J; Kolluri SK; Wu H; Cao Y; Chen J; Wu Y; Yan T; Cao X; Gao W; Molotkov A; Jiang F; Li WG; Lin B; Zhang HP; Yu J; Luo SP; Zeng JZ; Duester G; Huang PQ; Zhang XK
Cancer Cell; 2010 Jun; 17(6):560-73. PubMed ID: 20541701
[TBL] [Abstract][Full Text] [Related]
3. Antagonist effect of triptolide on AKT activation by truncated retinoid X receptor-alpha.
Lu N; Liu J; Liu J; Zhang C; Jiang F; Wu H; Chen L; Zeng W; Cao X; Yan T; Wang G; Zhou H; Lin B; Yan X; Zhang XK; Zeng JZ
PLoS One; 2012; 7(4):e35722. PubMed ID: 22545132
[TBL] [Abstract][Full Text] [Related]
4. Modulation of nongenomic activation of PI3K signalling by tetramerization of N-terminally-cleaved RXRα.
Chen L; Aleshin AE; Alitongbieke G; Zhou Y; Zhang X; Ye X; Hu M; Ren G; Chen Z; Ma Y; Zhang D; Liu S; Gao W; Cai L; Wu L; Zeng Z; Jiang F; Liu J; Zhou H; Cadwell G; Liddington RC; Su Y; Zhang XK
Nat Commun; 2017 Jul; 8():16066. PubMed ID: 28714476
[TBL] [Abstract][Full Text] [Related]
5. Nitrostyrene Derivatives Act as RXRα Ligands to Inhibit TNFα Activation of NF-κB.
Zeng Z; Sun Z; Huang M; Zhang W; Liu J; Chen L; Chen F; Zhou Y; Lin J; Huang F; Xu L; Zhuang Z; Guo S; Alitongbieke G; Xie G; Xu Y; Lin B; Cao X; Su Y; Zhang XK; Zhou H
Cancer Res; 2015 May; 75(10):2049-60. PubMed ID: 25795708
[TBL] [Abstract][Full Text] [Related]
6. NSC-640358 acts as RXRα ligand to promote TNFα-mediated apoptosis of cancer cell.
Chen F; Chen J; Lin J; Cheltsov AV; Xu L; Chen Y; Zeng Z; Chen L; Huang M; Hu M; Ye X; Zhou Y; Wang G; Su Y; Zhang L; Zhou F; Zhang XK; Zhou H
Protein Cell; 2015 Sep; 6(9):654-666. PubMed ID: 26156677
[TBL] [Abstract][Full Text] [Related]
7. Overview of the structure-based non-genomic effects of the nuclear receptor RXRα.
Chen L; Wu L; Zhu L; Zhao Y
Cell Mol Biol Lett; 2018; 23():36. PubMed ID: 30093910
[TBL] [Abstract][Full Text] [Related]
8. Sulindac-derived RXRα modulators inhibit cancer cell growth by binding to a novel site.
Chen L; Wang ZG; Aleshin AE; Chen F; Chen J; Jiang F; Alitongbieke G; Zeng Z; Ma Y; Huang M; Zhou H; Cadwell G; Zheng JF; Huang PQ; Liddington RC; Zhang XK; Su Y
Chem Biol; 2014 May; 21(5):596-607. PubMed ID: 24704507
[TBL] [Abstract][Full Text] [Related]
9. Regulation of proteolytic cleavage of retinoid X receptor-α by GSK-3β.
Gao W; Liu J; Hu M; Huang M; Cai S; Zeng Z; Lin B; Cao X; Chen J; Zeng JZ; Zhou H; Zhang XK
Carcinogenesis; 2013 Jun; 34(6):1208-15. PubMed ID: 23389291
[TBL] [Abstract][Full Text] [Related]
10. Regulation of the nongenomic actions of retinoid X receptor-α by targeting the coregulator-binding sites.
Zhang XK; Su Y; Chen L; Chen F; Liu J; Zhou H
Acta Pharmacol Sin; 2015 Jan; 36(1):102-12. PubMed ID: 25434990
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and SAR study of modulators inhibiting tRXRα-dependent AKT activation.
Wang ZG; Chen L; Chen J; Zheng JF; Gao W; Zeng Z; Zhou H; Zhang XK; Huang PQ; Su Y
Eur J Med Chem; 2013 Apr; 62():632-48. PubMed ID: 23434637
[TBL] [Abstract][Full Text] [Related]
12. Oncogenic potential of truncated RXRα during colitis-associated colorectal tumorigenesis by promoting IL-6-STAT3 signaling.
Ye X; Wu H; Sheng L; Liu YX; Ye F; Wang M; Zhou H; Su Y; Zhang XK
Nat Commun; 2019 Apr; 10(1):1463. PubMed ID: 30931933
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis and biological evaluation of tetrazole-containing RXRα ligands as anticancer agents.
Yan Z; Chong S; Lin H; Yang Q; Wang X; Zhang W; Zhang X; Zeng Z; Su Y
Eur J Med Chem; 2019 Feb; 164():562-575. PubMed ID: 30634084
[TBL] [Abstract][Full Text] [Related]
14. Discovery of atorvastatin as a tetramer stabilizer of nuclear receptor RXRα through structure-based virtual screening.
Wang X; Chong S; Lin H; Yan Z; Huang F; Zeng Z; Zhang X; Su Y
Bioorg Chem; 2019 Apr; 85():413-419. PubMed ID: 30665035
[TBL] [Abstract][Full Text] [Related]
15. TRC4, an improved triptolide derivative, specifically targets to truncated form of retinoid X receptor-alpha in cancer cells.
Wang PY; Zeng WJ; Liu J; Wu YL; Ma Y; Zeng Z; Pang JY; Zhang XK; Yan X; Wong AST; Zeng JZ
Biochem Pharmacol; 2017 Jan; 124():19-28. PubMed ID: 27810320
[TBL] [Abstract][Full Text] [Related]
16. Inflammatory mediators increase SUMOylation of retinoid X receptor α in a c-Jun N-terminal kinase-dependent manner in human hepatocellular carcinoma cells.
Schneider Aguirre R; Karpen SJ
Mol Pharmacol; 2013 Aug; 84(2):218-26. PubMed ID: 23690070
[TBL] [Abstract][Full Text] [Related]
17. Binding characterization, synthesis and biological evaluation of RXRα antagonists targeting the coactivator binding site.
Xu D; Guo S; Chen Z; Bao Y; Huang F; Xu D; Zhang X; Zeng Z; Zhou H; Zhang X; Su Y
Bioorg Med Chem Lett; 2016 Aug; 26(16):3846-9. PubMed ID: 27450787
[TBL] [Abstract][Full Text] [Related]
18. IL-1β induced RXRα overexpression through activation of NF-κB signaling in gastric carcinoma.
Ren HY; Huang GL; Liu WM; Zhang W; Liu Y; Su GQ; Shen DY
Biomed Pharmacother; 2016 Mar; 78():329-334. PubMed ID: 26898458
[TBL] [Abstract][Full Text] [Related]
19. Retinoid X receptor α enhances human cholangiocarcinoma growth through simultaneous activation of Wnt/β-catenin and nuclear factor-κB pathways.
Huang GL; Zhang W; Ren HY; Shen XY; Chen QX; Shen DY
Cancer Sci; 2015 Nov; 106(11):1515-23. PubMed ID: 26310932
[TBL] [Abstract][Full Text] [Related]
20. RXRα provokes tumor suppression through p53/p21/p16 and PI3K-AKT signaling pathways during stem cell differentiation and in cancer cells.
Zhang R; Li H; Zhang S; Zhang Y; Wang N; Zhou H; He H; Hu G; Zhang TC; Ma W
Cell Death Dis; 2018 May; 9(5):532. PubMed ID: 29748541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
